SCHEMBL21133664

SCHEMBL21133664

CCCCC/C=C/C(=O)/C=C/c1cc(OC)c(O)c(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.53
CYP2D6 P10635 3/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2B6 P20813 2/20 0.53
ALOX5 P09917 8/20 0.51
STAT3 P40763 4/20 0.51
NFKB1 P19838 3/20 0.51
NFKB2 Q00653 3/20 0.51
RELA Q04206 3/20 0.51
NFE2L2 Q16236 3/20 0.51
APP P05067 1/20 0.46
PTGES O14684 2/20 0.46
PTGS1 P23219 2/20 0.44
LTA4H P09960 3/20 0.43
PKM P14618 1/20 0.43
PTGS2 P35354 1/20 0.43
HTR1A P08908 5/20 0.43
CYP2E1 P05181 1/20 0.43
CYP2C8 P10632 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21133746 0.84 CYP1A2 (0.42) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL17527415 0.78 CYP2D6 (0.71) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL17527436 0.78 CYP2D6 (0.71) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL30335087 0.77 CYP2D6 (0.69) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL29929370 0.77 CYP2D6 (0.69) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL29929008 0.77 CYP2D6 (0.69) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL30334920 0.77 CYP2D6 (0.69) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL5702708 0.77 CYP2D6 (0.69) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL2743841 0.72 CYP1A2 (1.00) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL2743839 0.72 CYP1A2 (1.00) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10363230-B2 6-shogaol derivatives and activities thereof NORTH CAROLINA AGRICULTURAL AND TECHNICAL STATE UNIVERSITY (US) 2019-07-30 US disclosed
US-10342766-B2 6-shogaol derivatives and activities thereof NORTH CAROLINA AGRICULTURAL AND TECHNICAL STATE UNIVERSITY (US) 2019-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10363230-B2 6-shogaol derivatives and activities thereof NFE2L2, HMOX1, KEAP1 CYP1A2 267/4885CYP2D6 71/4885CYP3A4 476/4885
US-10342766-B2 6-shogaol derivatives and activities thereof NFE2L2, HMOX1, KEAP1 CYP1A2 267/4885CYP2D6 71/4885CYP3A4 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.